Sherilyn Baughman MD in Alamo, California

Medical School: Loma Linda University School Of Medicine
Graduation Year: 1981
The Primary Medical Specialty for Sherilyn Baughman MD is listed as: Dermatology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 43
PAC (PECOS ID)#: 5496760977
NPI #: 1326108713
NPI Created On: 12/08/2006
NPI Last Updated Listed as: 08/24/2012
Primary Taxonomy Code: 207ND0101X
License Number:
G48323
Listed Gender: Female

Forms of insurance accepted by include, but are not limited to:

• Humana
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Tangential biopsy of single skin lesion
2. Tangential biopsy of additional skin lesion
3. Punch biopsy of single skin lesion
4. Injection of up to 7 skin growths
5. Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs
6. Destruction of skin growth
7. Destruction of 2-14 skin growths
8. Destruction of 15 or more skin growths
9. Destruction of up to 14 skin growths
10. Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks)
11. Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals
12. Application of light and light-sensitive drugs to aid destruction of premalignant skin growths, per day
13. New patient office or other outpatient visit, typically 20 minutes
14. New patient office or other outpatient visit, typically 30 minutes
15. Established patient office or other outpatient visit, typically 15 minutes
16. Established patient office or other outpatient, visit typically 25 minutes
17. Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within t
18. Injection, triamcinolone acetonide, not otherwise specified, 10 mg
19. Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)